Company Profiles

driven by the PitchBook Platform

Tolera Therapeutics

Description

Developer of immune modulation transplant therapies. The company develops products to aid patients in anti-rejection therapy, immune modulation and oncology. Its products primarily serve the organ transplant, immune modulation and oncology markets.

2007

Founded

PRIVATE

Status

11-50

Employees

Conv. Debt

Latest Deal Type

$1.3M

Latest Deal Amount

$19M

Total Amount Raised

Description

Developer of immune modulation transplant therapies. The company develops products to aid patients in anti-rejection therapy, immune modulation and oncology. Its products primarily serve the organ transplant, immune modulation and oncology markets.

Website:

www.tolera.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Pharmaceuticals

Primary Office

P.O. Box 970 Portage, MI 49081United States +1 (269) 585-2100
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Tolera Therapeutics's full profile, request a free trial.

    Tolera Therapeutics Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Tolera Therapeutics Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Tolera Therapeutics Investors (9)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Apjohn VenturesVenture CapitalMinority000 0000000 0000
    Biosciences Research and Commercialization CenterVenture CapitalMinority000 0000000 0000
    Cleveland Clinic InnovationsCorporate Venture CapitalMinority000 0000000 0000
    Grand AngelsAngel GroupMinority000 0000000 0000
    Hopen Life Science VenturesVenture CapitalMinority000 0000000 0000
    Apjohn Ventures Venture Capital
    Biosciences Research and Commercialization Center Venture Capital
    Cleveland Clinic Innovations Corporate Venture Capital
    Grand Angels Angel Group
    Hopen Life Science Ventures Venture Capital

    Tolera Therapeutics Executive Team (3)

    NameTitleBoard
    Seat
    Contact
    Info
    Harry Ledebur Ph.DChief Executive Officer & Board Member
    Melissa VrbaProject Manager
    Suzette DutchChairman
    Harry Ledebur Ph.D Chief Executive Officer & Board Member
    Melissa Vrba Project Manager
    Suzette Dutch Chairman

    Tolera Therapeutics Board Members (6)

    NameRepresentingRoleSinceContact
    Info
    Donald ParfetApjohn VenturesCo-Founder & General Partner000 0000
    Douglas Morton Ph.DSelfBoard Member000 0000
    Harry Ledebur Ph.DTolera TherapeuticsChief Executive Officer & Board Member000 0000
    Mark OlesnavageHopen Life Science VenturesCo-Founder & Managing Director000 0000
    Paul D'AmatoGrand AngelsManaging Director & Board Member000 0000
    Donald Parfet Co-Founder & General Partner Apjohn Ventures
    Douglas Morton Ph.D Board Member Self
    Harry Ledebur Ph.D Chief Executive Officer & Board Member Tolera Therapeutics
    Mark Olesnavage Co-Founder & Managing Director Hopen Life Science Ventures
    Paul D'Amato Managing Director & Board Member Grand Angels
    Request full access to PitchBook